Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 10Sarcoma 4Lymphoid 1Head & Neck 1

Conditions

Lymphoma 5Lymphoma, Follicular 2Oligodendroglioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Filgrastim 4Magnetic Resonance Spectroscopy 3Dexamethasone 3entrectinib 2Vincristine 2Temozolomide 2Pemetrexed 2Methylphenidate 2Methods 2Drug Therapy 2Cytarabine 2Cyclophosphamide 2Carmustine 2trametinib 1sonidegib 1selinexor 1sargramostim 1ribociclib 1gadobutrol 1gadobenic acid 1entinostat 1cc-486 1carboxyamido-triazole 1alovudine 1alectinib 1Zidovudine 1Watchful Waiting 1WP 744 1Topotecan 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Chemotherapy, Adjuvant × Lymphoid × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡